"<l&j^0in re Application of
Docket No.: 50229-435
IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
Customer Number: 20277
Jeffrey A. MOSCOW, et al.
Confirmation Number: 7209
Application No. : 1 0/849,55 1
Group Art Unit: 1645
Filed: May 20, 2004
Examiner: Not yet assigned
For: AN ORGANIC CATION TRANSPORTER PREFERENTIALLY EXPRESSED IN
Mail Stop Amendment
Commissioner for Patents
P.O. Box 1450
Alexandria, VA 22313-1450
In accordance with the provisions of 37 C.F.R. 1 .56, 1 .97 and 1 .98, the attention of the
Patent and Trademark Office is hereby directed to the documents listed on the attached form PTO-
1449. It is respectfully requested that the documents be expressly considered during the prosecution
of this application, and that the documents be made of record therein and appear among the
"References Cited' 1 on any patent to issue therefrom.
This Information Disclosure Statement is being filed within three months of the U.S. filing
date OR before the mailing date of a first Office Action on the merits. No certification or fee is
INFORMATION DISCLOSURE STATEMENT
Please charge any shortage in fees due in connection with the filing of this paper,
including extension of time fees, to Deposit Account 500417 and please credit any excess fees to
such deposit account.
McDERMOTT WILL & EMERY LLP
Thomas A. Haag, Ph.D., Esq.
Registration No. 47,621
600 13 Street, N.W. Please recognize our Customer No. 20277
Washington, DC 20005-3096 as our correspondence address.
Phone: 202.756.8000 TAH:blg
Date: December 16, 2004
DEC 1 6-2004-
SHEET 1 OF 1
CITATION IN AN
ATTY. DOCKET NO.
Jeffrey A. MOSCOW, et al.
May 20, 2004
U.S. PATENT DOCUMENTS
Number-Kind Code2 (it known)
Name of Patentee or Applicant of Cited
Pages, Columns, Lines, Where
Relevant Passages or Relevant
FOREIGN PATENT DOCUMENTS
Foreign Patent Document
Country Code3 -Number 4 -Kind
Codes (if known)
Name of Patentee or
Applicant of Cited Document
Pages, Columns, Lines
OTHER ART (Including Author, Title, Date, Pertinent Pages, Etc.)
Include name of the author (in CAPITAL LETTERS), title of the article (when appropriate), title of the item (book, magazine,
journal, serial, symposium, catalog, etc.), date, page(s), volume-issue number(s), publisher, city and/or country where
Biochem. Pharmacol. "Short Communications" Vol. 11: pp. 1233-1234, Pergamon Press Ltd., 1962
Moscow, et al., "Isolation of a Gene Encoding a Human Reduced Folate Carrier (RFC1) and Analysis of Its
Expression in Transport-deficient, Methotrexate-resistant Human Breast Cancer Cells" Cancer Res. 55: pp. 3790-
Moscow et al., "Reduced Folate Carrier Gene (RFC1) Expression and Anti-Folate Resistance in Transfected and Non-
Selected Cell Lines" Int J Cancer. 72: pp. 184-190, 1997
Koepsell et al., "Organic Cation Transporters in Intestine, Kidney, Liver, and Brain" Ann. Rev. Physiol. 60: pp. 243-
Burckhardt, et al., "Structure of renal organic anion and cation transporters" Am J Physiol Renal Physiol. 278: pp.
Wu, et al., "Identity of the Organic Cation Transporter OCT3 as the Extraneuronal Monoamine Transporter (uptake 2 )
and Evidence for the Expression of the Transporter in the Brain" J Biot Chem. 273: pp. 32776-86, 1998
Dhillon et at. Clin Pharmacol Then 65: p. 205, 1996
Koyama et al., "CD63, a Member of Tetraspan Transmembrane Protein Family, Induces Cellular Spreading by
Reaction with Monoclonal Antibody on Substrata" Biochem Biophys Res Commun. 246: pp. 841-846, 1998
Moscow, J. A., Schneider, E. S., Ivy, S. P., and Cowan, K. H. "Multidrug resistance" In: H. M. Pinedo, D. L. Longo, and
B. A. Chabner (eds.), Cancer chemotherapy and biological response modifiers. Annual 17. New York: Elsevier, pp.
•EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance and not considered.
Include copy of this form with next communication to applicant.
1 Applicant's unique citation designation number (optional). 2 Applicant is to place a check mark here if English language Translation is attached.